Lack Of Ebola Patients In Liberia Leads Drug Developer To Halt Experimental Treatment Clinical Trial
New York Times: Ebola Drug Trial Is Halted for Lack of Patients
“A clinical trial in Liberia of a drug to treat Ebola has been halted because of a sharp decline in the number of people infected with the virus, and studies in West Africa of other potential treatments are also facing problems finding patients…” (Pollack, 2/1).
Reuters: Chimerix to stop participation in clinical studies of Ebola drug
“Drug developer Chimerix Inc. said it would stop participation in clinical studies of its Ebola drug, brincidofovir, citing a significant decrease in the number of new cases for the virus in Liberia…” (Sikka/Koppalla, 1/30).